<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0141399</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-34426</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Lactobacillus casei</italic> Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study</article-title>
<alt-title alt-title-type="running-head">No Impact of <italic>Lc</italic>S on Gut Microbiota and Barrier in MetS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Stadlbauer</surname>
<given-names>Vanessa</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Leber</surname>
<given-names>Bettina</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lemesch</surname>
<given-names>Sandra</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Trajanoski</surname>
<given-names>Slave</given-names>
</name>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bashir</surname>
<given-names>Mina</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Horvath</surname>
<given-names>Angela</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tawdrous</surname>
<given-names>Monika</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Stojakovic</surname>
<given-names>Tatjana</given-names>
</name>
<xref rid="aff005" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fauler</surname>
<given-names>Günter</given-names>
</name>
<xref rid="aff005" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fickert</surname>
<given-names>Peter</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Högenauer</surname>
<given-names>Christoph</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Klymiuk</surname>
<given-names>Ingeborg</given-names>
</name>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Stiegler</surname>
<given-names>Philipp</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lamprecht</surname>
<given-names>Manfred</given-names>
</name>
<xref rid="aff006" ref-type="aff"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Pieber</surname>
<given-names>Thomas R.</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
<xref rid="aff007" ref-type="aff"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tripolt</surname>
<given-names>Norbert J.</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Sourij</surname>
<given-names>Harald</given-names>
</name>
<xref rid="aff004" ref-type="aff"><sup>4</sup></xref>
<xref rid="aff007" ref-type="aff"><sup>7</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Medical University of Graz, Division of Gastroenterology and Hepatology, Graz, Austria</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Medical University of Graz, Division of Transplantation Surgery, Graz, Austria</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Centre for Medical Research, Graz, Austria</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Medical University of Graz, Division of Endocrinology and Metabolism, Graz, Austria</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Medical University of Graz, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Graz, Austria</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Medical University of Graz, Institute of Physiological Chemistry, Centre for Physiological Medicine, Graz, Austria</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Centre for Biomarker Research in Medicine (CBmed), Graz, Austria</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Wong</surname>
<given-names>Vincent</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>The Chinese University of Hong Kong, HONG KONG</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: VS HS. Performed the experiments: BL MT AH IK SL MB NJT. Analyzed the data: VS BL SL ST AH MB. Contributed reagents/materials/analysis tools: TS ST IK. Wrote the paper: VS BL SL ST MB AH MT TS GF PF CH IK PS ML TRP NJT HS.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">slave.trajanoski@medunigraz.at</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>10</issue>
<elocation-id>e0141399</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Stadlbauer et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0141399" xlink:type="simple"/>
<abstract>
<p>Metabolic syndrome is associated with disturbances in gut microbiota composition. We aimed to investigate the effect of <italic>Lactobacillus casei</italic> Shirota (<italic>Lc</italic>S) on gut microbiota composition, gut barrier integrity, intestinal inflammation and serum bile acid profile in metabolic syndrome. In a single-centre, prospective, randomised controlled pilot study, 28 subjects with metabolic syndrome received either <italic>Lc</italic>S for 12 weeks (n = 13) or no <italic>Lc</italic>S (n = 15). Data were compared to healthy controls (n = 16). Gut microbiota composition was characterised from stool using 454 pyrosequencing of 16S rRNA genes. Serum bile acids were quantified by tandem mass spectrometry. Zonulin and calprotectin were measured in serum and stool by ELISA. <italic>Bacteroidetes/Firmicutes</italic> ratio was significantly higher in healthy controls compared to metabolic syndrome but was not influenced by <italic>Lc</italic>S. <italic>Lc</italic>S supplementation led to enrichment of <italic>Parabacteroides</italic>. Zonulin and calprotectin were increased in metabolic syndrome stool samples but not influenced by <italic>Lc</italic>S supplementation. Serum bile acids were similar to controls and not influenced by <italic>Lc</italic>S supplementation. Metabolic syndrome is associated with a higher <italic>Bacteroidetes/Firmicutes</italic> ratio and gut barrier dysfunction but <italic>Lc</italic>S was not able to change this. <italic>Lc</italic>S administration was associated with subtle microbiota changes at genus level.</p>
<sec id="sec001">
<title>Trial Registration</title>
<p>ClinicalTrials.gov <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/ct2/show/NCT01182844" xlink:type="simple">NCT01182844</ext-link></p>
</sec>
</abstract>
<funding-group>
<funding-statement>Yakult Europe provided the study product but did not further support this study or its authors. VS, AH, SL and MT are supported by grants from the Austrian Science Foundation (FWF): P24362-B23 and P23532-B18. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="2"/>
<table-count count="3"/>
<page-count count="14"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec002" sec-type="intro">
<title>Introduction</title>
<p>The obesity epidemic is a challenging threat to public health in the 21<sup>st</sup> century. The World Health Organisation states that by 2014 approximately 1.9 billion adults are overweight (BMI 25–29.9 kg/m<sup>2</sup>), and more than 600 million are obese (BMI 30 kg/m<sup>2</sup> or more). [<xref rid="pone.0141399.ref001" ref-type="bibr">1</xref>] Obesity and insulin resistance are major risk factors for the development of metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM), and conditions such as cardiovascular morbidity and mortality. [<xref rid="pone.0141399.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0141399.ref003" ref-type="bibr">3</xref>]</p>
<p>The pathogenesis of obesity is multifactorial and is seen as interplay between individual phenotype and environmental factors. However, recent preclinical and clinical studies show an important influence of the intestinal microbiota on obesity and associated metabolic disorders (MetS, T2DM, metabolic liver diseases, cardiovascular diseases). [<xref rid="pone.0141399.ref004" ref-type="bibr">4</xref>] The cecum microbiota of obese mice was found to be significantly different with a higher prevalence of <italic>Firmicutes</italic> and a corresponding lower prevalence of <italic>Bacteroidetes</italic> (lower <italic>Bacteroidetes/Firmicutes</italic> ratio) in obese compared to lean mice. [<xref rid="pone.0141399.ref005" ref-type="bibr">5</xref>] This finding of altered gut microbiota was then confirmed and extended to humans. [<xref rid="pone.0141399.ref006" ref-type="bibr">6</xref>] However, others did not find this association in obesity or MetS. [<xref rid="pone.0141399.ref007" ref-type="bibr">7</xref>–<xref rid="pone.0141399.ref010" ref-type="bibr">10</xref>] Further studies have shown an association of gut microbiota changes with insulin resistance and diabetes. [<xref rid="pone.0141399.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0141399.ref012" ref-type="bibr">12</xref>] This suggests that the microbiota might be involved in the pathogenesis of obesity, insulin resistance and T2DM, possibly by having an impact on gut barrier integrity and inflammation. [<xref rid="pone.0141399.ref004" ref-type="bibr">4</xref>] Also, hydrophobic bile acids have been proposed as a novel mechanism for high fat diet induced gut barrier dysfunction. [<xref rid="pone.0141399.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0141399.ref014" ref-type="bibr">14</xref>] Probiotic interventions have been shown to be effective in modulating gut barrier integrity and gut microbiota in animals and thereby modulating chronic inflammation and metabolic disorders in animal models. [<xref rid="pone.0141399.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0141399.ref016" ref-type="bibr">16</xref>] Despite several mechanistic studies and encouraging results in animals [<xref rid="pone.0141399.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0141399.ref018" ref-type="bibr">18</xref>] interventional data on probiotics use in humans with MetS are rare. [<xref rid="pone.0141399.ref019" ref-type="bibr">19</xref>]</p>
<p>The aim of our study was to investigate the effect of <italic>Lactobacillus casei</italic> Shirota (<italic>Lc</italic>S) on gut microbiota composition, gut barrier integrity, intestinal inflammation and the serum bile acid profile in MetS.</p>
</sec>
<sec id="sec003" sec-type="materials|methods">
<title>Patients and Methods</title>
<sec id="sec004">
<title>Patients and Controls</title>
<p>The study was conducted according to the Declaration of Helsinki and all procedures involving human subjects were approved by the Ethics Committee of the Medical University of Graz (20–037 ex 08/09). The study was registered at ClinicalTrials.gov (NCT01182844). Due to an unexpected organizational delay in the registration process of the study the initial release of the protocol in ClinicalTrials.gov took place after the first patient was randomized. The authors confirm that they have not performed and are not conducting any other trials with this intervention (<italic>Lactobacillus casei</italic> Shirota). Written informed consent was obtained from all subjects. The primary and parts of the secondary outcomes were already published [<xref rid="pone.0141399.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0141399.ref021" ref-type="bibr">21</xref>]. The gut microbiome analysis was delayed due to lack of funding. The Ethics Committee of the Medical University was informed about the delay in analysis and about all changes in the study protocol. These changes were methodological changes since the methods for gut microbiome analysis and gut permeability analysis have advanced since the start of the study. Furthermore the analysis of bile acids has been added to the protocol and was approved by the Ethics Committee of the Medical University.</p>
<p>According to the modified NCEP-ATP-III-guidelines [<xref rid="pone.0141399.ref022" ref-type="bibr">22</xref>] patients with MetS were identified from the outpatient clinic at the Division of Endocrinology and Metabolism at the Medical University of Graz. Patients treated with antibiotics within the previous 7 days, with current anti-hyperglycemic treatment, any immunomodulatory therapy 1 month prior to study entry, concomitant use of pre-, pro-, or synbiotics, inflammatory bowel disease (Crohn`s disease, ulcerative colitis) or celiac disease or those with clinical signs of infectious diseases were excluded from participation. We performed a single-centre, permuted-block randomised controlled 12 weeks prospective intervention trial. Patients were randomised to receive either food supplementation with a milk drink containing <italic>Lc</italic>S (3 bottles a day, à 65ml, containing <italic>Lc</italic>S at a concentration of 10<sup>8</sup>/ml, Yakult light®, Yakult Austria, Vienna, Austria) for twelve weeks (n = 13, LcS group) or no intervention (n = 15, standard therapy group).</p>
<p>Patients were randomised with the “Randomizer®” software using permutated blocks (Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Austria). All patients were advised to consume no other probiotic supplements during the study period and received a list of probiotic products available in Austria, which they had to avoid for the study period. Participants were also advised not to change their diet and physical activity pattern while being in the study. A food frequency questionnaire was used to confirm unchanged diet habits. [<xref rid="pone.0141399.ref020" ref-type="bibr">20</xref>] Subjects of the <italic>Lc</italic>S group were provided with a pack of the milk drink every two weeks. At these time points intervention adherence was assessed.</p>
<p>Stool and serum samples were collected at baseline and after 12 weeks. Stool samples from 16 healthy, lean controls without evidence of metabolic syndrome were used as a comparison for gut microbiota analysis and zonulin levels. For stool calprotectin established reference ranges from the kit description were used. Serum samples from 11 healthy, lean controls were used to compare bile acid profiles, zonulin, and calprotectin levels in serum.</p>
</sec>
<sec id="sec005">
<title>DNA-isolation, 454 library preparation and sequencing</title>
<p>Stool samples were immediately frozen and stored at -80°C until semi-automated DNA isolation. Approximately 175mg of stool was homogenized in MagnaLyser Green Bead tubes by using the MagnaLyser Instrument (Roche Diagnostics, Mannheim, Germany) according to manufacturer’s instructions. Total genomic DNA was isolated with the MagNA Pure LC DNA Isolation Kit III (Bacteria, Fungi) in a MagNA Pure LC 2.0 Instrument (Roche Diagnostics, Mannheim, Germany) according to manufacturer’s instructions. Enzyme cocktail II (Roche Diagnostics, Mannheim, Germany) with 100μg lysozyme (Karl Roth GmbH, Karlsruhe, Germany) per 100μl sample was used according to manufacturer’s instructions.</p>
<p>The 16S rRNA gene was amplified using FLX 454 one way read (Lib-L kit, Primer A, Primer B, Roche 454 Life Science, Branford, CT, USA) (<xref rid="pone.0141399.s003" ref-type="supplementary-material">S1 Table</xref>) fusion primers with the template specific sequence F27—AGAGTTTGATCCTGGCTCAG and R534—ATTACCGCGGCTGCTGGC targeting the V1-V3 hypervariable regions [<xref rid="pone.0141399.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0141399.ref024" ref-type="bibr">24</xref>] as described previously in Kump et al. 2013. [<xref rid="pone.0141399.ref025" ref-type="bibr">25</xref>]</p>
</sec>
<sec id="sec006">
<title>Zonulin and calprotectin</title>
<p>A ready-to-use solid-phase sandwich ELISA (Immundiagnostik AG, Bensheim, Germany) was used to detect zonulin (zonulin Serum or Stool ELISA) and calprotectin (PhiCal® calprotectin Serum or Stool ELISA) in serum and stool samples. The tests were performed according to the manufacturer’s instructions. For stool sampling the Stool Sample Application System (Immundiagnostik AG, Bensheim, Germany) was used according to the manufacturer’s manual.</p>
</sec>
<sec id="sec007">
<title>Bile acids</title>
<p>All bile acids (cholic acid, CA; deoxycholic acid, DCA; chenodeoxycholic acid, CDCA; lithocholic acid, LCA; ursodeoxycholic acid, UDCA) were assessed as unconjugated acids and as taurine and glycine conjugates using a tandem mass spectrometry method as described previously. [<xref rid="pone.0141399.ref026" ref-type="bibr">26</xref>] All sub-fractions of bile acids (free acids and their corresponding conjugates) were analysed by three different multiple-reaction monitoring experiments within one HPLC run. HPLC was performed on a reversed-phase (C18) column that used a methanol/water gradient for chromatographic solution of isobaric bile acids. Deuterated internal standards and correlation of peak area ratios in linear regression were used for quantification of all sub-fractions of bile acids.</p>
<sec id="sec008">
<title>Data analysis</title>
<p>Raw sequencing data generated on the Genome Sequencer FLX system were de-noised with Acacia 1.52. Afterwards reads were pre-processed with several quality parameters to trim primer and barcode sequences and filter low quality reads according to suggestions described in Huse et.al. [<xref rid="pone.0141399.ref027" ref-type="bibr">27</xref>]. Data analysis was performed in QIIME 1.7.0 [<xref rid="pone.0141399.ref028" ref-type="bibr">28</xref>] and included following steps: clustering of high quality reads into operational taxonomic units (OTUs) using UCLUST [<xref rid="pone.0141399.ref029" ref-type="bibr">29</xref>] and similarity of 0.97; taxonomy assignment of the OTUs with RDP classifier [<xref rid="pone.0141399.ref030" ref-type="bibr">30</xref>] and confidence score of 0.8 based on GreenGenes [<xref rid="pone.0141399.ref031" ref-type="bibr">31</xref>]16S rRNA database; representative sequence alignment with PyNAST [<xref rid="pone.0141399.ref032" ref-type="bibr">32</xref>]; detection and removal of chimeric sequences with ChimeraSlayer; [<xref rid="pone.0141399.ref033" ref-type="bibr">33</xref>] generating a phylogenetic tree with FastTree [<xref rid="pone.0141399.ref034" ref-type="bibr">34</xref>]. Additionally singletons (OTUs with one read present only in one sample) were removed to avoid overestimation of the sample richness and diversity. Finally, the resulting OTU table and accompanied phylogenetic tree were further used for calculation of alpha and beta diversity. Alpha diversity indices were determined with the R statistical programming language extended with Vegan and BiodiversityR community ecology packages whereas beta diversity was done in QIIME involving data rarefaction to the smallest sample size and selecting two distance measurements, weighted UniFrac and Bray-Curtis distance for the Principal Coordinates Analysis (PCoA) diagrams and between samples comparisons. Testing whether groups of the samples were significantly different was assessed with the non-parametric MANOVA method implemented in the Vegan package (Adonis) or with Student’s t-Test and ANOVA as implemented in R environment.</p>
<p>We searched for <italic>Lactobacilli</italic>, because sequencing only a fragment of the 16S rRNA gene does not allow us to determine species with a high confidence.</p>
<p>Searching for <italic>Akkermansia</italic> was done using taxonomic information in the OTU table.</p>
<p>All other statistical analyses were performed using SPSS 18.0 software (SPSS Inc, Chicago). The Mann-Whitney-U test or the unpaired student’s t-test were used for the comparison of differences between groups and the paired student’s t-test or the Wilcoxon signed-rank test for the before and after treatment measurements, as appropriate for normally and not-normally distributed variables, respectively. Differences with a p-value below 0.05 were considered statistically significant and for multiple tests we used Benjamini &amp; Hochberg correction.</p>
</sec>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<sec id="sec010">
<title>Patients</title>
<p>Thirty-five subjects were screened for the study between January and August 2010; 30 patients were finally included, whereof 28 finished the study (2 dropped out due to withdrawal of informed consent). Five patients did not fulfill the inclusion criterion of fasting glucose above 100 mg/dl at the day of screening any more. Thirteen patients were randomized to the probiotic group and 15 to the standard therapy group (<xref rid="pone.0141399.g001" ref-type="fig">Fig 1</xref>). Baseline characteristics of patients with MetS and a healthy control group are shown in <xref rid="pone.0141399.t001" ref-type="table">Table 1</xref>.</p>
<fig id="pone.0141399.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0141399.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram of the study progress.</title>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0141399.g001" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0141399.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0141399.t001</object-id>
<label>Table 1</label> <caption><title>Patient characteristics.</title> <p>Data are given as mean±SD.</p></caption>
<alternatives>
<graphic id="pone.0141399.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0141399.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th colspan="2" align="center" rowspan="1"><italic>Lc</italic>S (n = 13)</th>
<th colspan="2" align="center" rowspan="1">Standard therapy (n = 15)</th>
<th rowspan="2" align="center" colspan="1">Healthy (n = 16)</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1">base</th>
<th align="left" rowspan="1" colspan="1">EOS</th>
<th align="left" rowspan="1" colspan="1">base</th>
<th align="left" rowspan="1" colspan="1">EOS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Sex (female/male)</td>
<td align="left" rowspan="1" colspan="1">4/9</td>
<td align="left" rowspan="1" colspan="1">4/9</td>
<td align="left" rowspan="1" colspan="1">6/9</td>
<td align="left" rowspan="1" colspan="1">6/9</td>
<td align="left" rowspan="1" colspan="1">7/9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Age (years)</td>
<td align="left" rowspan="1" colspan="1">51±11</td>
<td align="left" rowspan="1" colspan="1">51±11</td>
<td align="left" rowspan="1" colspan="1">55±9</td>
<td align="left" rowspan="1" colspan="1">55±9</td>
<td align="left" rowspan="1" colspan="1">25±4<xref rid="t001fn003" ref-type="table-fn">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Height (cm)</td>
<td align="left" rowspan="1" colspan="1">175±8</td>
<td align="left" rowspan="1" colspan="1">175±8</td>
<td align="left" rowspan="1" colspan="1">169±8</td>
<td align="left" rowspan="1" colspan="1">169±8</td>
<td align="left" rowspan="1" colspan="1">172±8</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Weight (kg)</td>
<td align="left" rowspan="1" colspan="1">109±15</td>
<td align="left" rowspan="1" colspan="1">108±17</td>
<td align="left" rowspan="1" colspan="1">91±14<xref rid="t001fn002" ref-type="table-fn">**</xref></td>
<td align="left" rowspan="1" colspan="1">91±15</td>
<td align="left" rowspan="1" colspan="1">69±11<xref rid="t001fn003" ref-type="table-fn">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Blood pressure systolic (mmHg)</td>
<td align="left" rowspan="1" colspan="1">148±19</td>
<td align="left" rowspan="1" colspan="1">142±16</td>
<td align="left" rowspan="1" colspan="1">147±18</td>
<td align="left" rowspan="1" colspan="1">139±11</td>
<td align="left" rowspan="1" colspan="1">n.a.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Blood pressure diastolic (mmHg)</td>
<td align="left" rowspan="1" colspan="1">95±12</td>
<td align="left" rowspan="1" colspan="1">92±12</td>
<td align="left" rowspan="1" colspan="1">94±18</td>
<td align="left" rowspan="1" colspan="1">88±9</td>
<td align="left" rowspan="1" colspan="1">n.a.</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td>
<td align="left" rowspan="1" colspan="1">35±5</td>
<td align="left" rowspan="1" colspan="1">35±6</td>
<td align="left" rowspan="1" colspan="1">32±4<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
<td align="left" rowspan="1" colspan="1">32±4</td>
<td align="left" rowspan="1" colspan="1">23±3<xref rid="t001fn003" ref-type="table-fn">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td>
<td align="left" rowspan="1" colspan="1">113±12</td>
<td align="left" rowspan="1" colspan="1">112±12</td>
<td align="left" rowspan="1" colspan="1">106±8</td>
<td align="left" rowspan="1" colspan="1">106±9</td>
<td align="left" rowspan="1" colspan="1">76±8<xref rid="t001fn003" ref-type="table-fn">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Total cholesterol (mmol/l)</td>
<td align="left" rowspan="1" colspan="1">220±69</td>
<td align="left" rowspan="1" colspan="1">219±59</td>
<td align="left" rowspan="1" colspan="1">209±43</td>
<td align="left" rowspan="1" colspan="1">211±34</td>
<td align="left" rowspan="1" colspan="1">4.9±1</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">High density lipoproteins (mmol/l)</td>
<td align="left" rowspan="1" colspan="1">43±17</td>
<td align="left" rowspan="1" colspan="1">40±16</td>
<td align="left" rowspan="1" colspan="1">47±19</td>
<td align="left" rowspan="1" colspan="1">42±12</td>
<td align="left" rowspan="1" colspan="1">1.6±0.3<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Low density lipoproteins (mmol/l)</td>
<td align="left" rowspan="1" colspan="1">128±49</td>
<td align="left" rowspan="1" colspan="1">132±45</td>
<td align="left" rowspan="1" colspan="1">119±27</td>
<td align="left" rowspan="1" colspan="1">126±29</td>
<td align="left" rowspan="1" colspan="1">2.7±0.9</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Triglycerides (mmol/l)</td>
<td align="left" rowspan="1" colspan="1">214±169</td>
<td align="left" rowspan="1" colspan="1">202±123</td>
<td align="left" rowspan="1" colspan="1">170±106</td>
<td align="left" rowspan="1" colspan="1">159±66</td>
<td align="left" rowspan="1" colspan="1">1.2±0.5<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>*p&lt;0.05</p></fn>
<fn id="t001fn002"><p>**p&lt;0.01</p></fn>
<fn id="t001fn003"><p>***p&lt;0.001 compared to the other groups at baseline</p></fn>
<fn id="t001fn004"><p>n.a. not available; EOS: end of study; base: baseline; healthy: healthy controls.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec011">
<title>Gut microbiota</title>
<p>We generated 539,934 raw sequences with a mean length of 362bp. After de-noising and quality filtering, 390,021 reads (mean length 393bp) remained for downstream analysis. Chimeric sequences (18.5%) and singletons (2.71%, reads occurring only once in a single sample) were removed and not used for further analysis. The average number of reads per sample was 5,208 (SD 1,786; range 1,716–11,252). Rarefaction curves confirmed that sequencing effort was not sufficient to cover all rare taxa, but still the curve trends were approaching saturation, and did not show any specific group dependent characteristics.</p>
<sec id="sec012">
<title>Comparison between MetS patients and healthy controls</title>
<p><italic>Bacteroidetes/Firmicutes</italic> ratio was significantly lower in patients with MetS (median: 0.75; quartiles: 0.44–1.00; p&lt;0.0001) compared to healthy controls (median: 1.77; quartiles: 0.89–2.42; <xref rid="pone.0141399.g002" ref-type="fig">Fig 2A</xref>). We could recognize two groups of samples, where <italic>Bacteroides</italic> (68%) or <italic>Prevotella</italic> (15%) was most abundant as well as different other genera making the rest of the samples (17%). No statistical differences in the <italic>Bacteroides</italic> and <italic>Prevotella</italic> groups’ distribution between patients and controls were detected. No significant differences in UniFrac (p = 0.70) or Bray-Curtis (p = 0.48) distances between baseline and end of therapy were found. Evenness and diversity (Shannon and Simpson Index) of gut microbiota in MetS showed similar distribution compared to healthy controls (<xref rid="pone.0141399.t002" ref-type="table">Table 2</xref>).</p>
<fig id="pone.0141399.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0141399.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Gut microbiota composition in MetS patients and controls.</title>
<p><italic>Bacteroidetes</italic>/<italic>Firmicutes</italic> ratio (a) PCoA Plot (Weighted UniFrac, b) and abundance of <italic>Parabacteroides</italic> (c) concerning <italic>Lc</italic>S supplementation.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0141399.g002" position="float" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0141399.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0141399.t002</object-id>
<label>Table 2</label> <caption><title>Evenness and diversity of gut microbiota in MetS and healthy controls.</title> <p>Data are given as median (quartiles).</p></caption>
<alternatives>
<graphic id="pone.0141399.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0141399.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="justify" rowspan="1" colspan="1"/>
<th align="center" rowspan="1" colspan="1">MetS patients (n = 28)</th>
<th align="center" rowspan="1" colspan="1">Healthy controls (n = 16)</th>
<th align="center" rowspan="1" colspan="1">p-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify" rowspan="1" colspan="1">J-evenness</td>
<td align="justify" rowspan="1" colspan="1">0.62 (0.56–0.66)</td>
<td align="justify" rowspan="1" colspan="1">0.65 (0.59–0.66)</td>
<td align="justify" rowspan="1" colspan="1">0.238</td>
</tr>
<tr>
<td align="justify" rowspan="1" colspan="1">Shannon</td>
<td align="justify" rowspan="1" colspan="1">3.8 (3.5–4.2)</td>
<td align="justify" rowspan="1" colspan="1">3.9 (3.5–4.1)</td>
<td align="justify" rowspan="1" colspan="1">0.839</td>
</tr>
<tr>
<td align="justify" rowspan="1" colspan="1">Simpson</td>
<td align="justify" rowspan="1" colspan="1">0.91 (0.88–0.95)</td>
<td align="justify" rowspan="1" colspan="1">0.92 (0.87–0.95)</td>
<td align="justify" rowspan="1" colspan="1">0.985</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>MetS: metabolic syndrome.</p></fn>
</table-wrap-foot>
</table-wrap>
<p><italic>Akkermansia</italic>, a possibly relevant genus in the pathophysiology of MetS, was detectable in higher abundance in only one individual in the standard therapy group at baseline and at the end of the study (21.40% and 24.28%, respectively).</p>
</sec>
<sec id="sec013">
<title>Effect of supplementation of <italic>Lc</italic>S in MetS</title>
<p>Variations (UniFrac distances) in microbiota composition found in the <italic>Lc</italic>S group between baseline and end of the study were similar to variations in the standard therapy group. Diversity of gut microbiota in MetS was not influenced by <italic>Lc</italic>S supplementation. We also could not detect any significant changes in microbiota between the <italic>Lc</italic>S and standard therapy group at any time point using Adonis multivariate analysis. Weighted UniFrac PCoA plots showed no clear separation of the groups between the two time points and in comparison with the healthy controls (<xref rid="pone.0141399.g002" ref-type="fig">Fig 2B</xref>).</p>
<p>By looking at the most abundant genera however (present with more than 1% in at least 50% of the samples) we found a significantly increased proportion of <italic>Parabacteroides</italic> at the end of the study when compared to baseline in the <italic>Lc</italic>S group (p = 0.002). (<xref rid="pone.0141399.g002" ref-type="fig">Fig 2C</xref>)</p>
<p><italic>Lactobacillus</italic> genus was not detectable with our method.</p>
</sec>
</sec>
<sec id="sec014">
<title>Gut wall integrity and inflammation</title>
<p>Zonulin and calprotectin were studied as markers of gut barrier disruption and intestinal inflammation. Serum levels of zonulin and calprotectin were not elevated in patients compared to healthy controls. However, zonulin and calprotectin were significantly higher in stool samples of patients compared to controls (p&lt;0.001) or compared to the median of healthy controls from the kit description (p = 0.017). Both zonulin and calprotectin levels were not influenced by <italic>Lc</italic>S administration. Baseline data for zonulin and calprotectin are shown in <xref rid="pone.0141399.t003" ref-type="table">Table 3</xref>.</p>
<table-wrap id="pone.0141399.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0141399.t003</object-id>
<label>Table 3</label> <caption><title>Zonulin and Calprotectin concentrations in serum and stool of MetS patients and controls.</title> <p>Data are given as median (quartiles).</p></caption>
<alternatives>
<graphic id="pone.0141399.t003g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0141399.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1">MetS patients (n = 28)</th>
<th align="left" rowspan="1" colspan="1">Normal range<xref rid="t003fn001" ref-type="table-fn">#</xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Serum zonulin (ng/ml)</td>
<td align="left" rowspan="1" colspan="1">45 (39–50)</td>
<td align="left" rowspan="1" colspan="1">52 (47–60)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Serum calprotectin (ng/ml)</td>
<td align="left" rowspan="1" colspan="1">555 (432.5–771.3)</td>
<td align="left" rowspan="1" colspan="1">570 (490–1050)</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Stool zonulin (ng/ml)</td>
<td align="left" rowspan="1" colspan="1">75 (55–105)</td>
<td align="left" rowspan="1" colspan="1">31 (26–38) <xref rid="t003fn002" ref-type="table-fn">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Stool calprotectin (μg/ml)</td>
<td align="left" rowspan="1" colspan="1">29 (14.1–102.5)</td>
<td align="left" rowspan="1" colspan="1">25<xref rid="t003fn003" ref-type="table-fn">*</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p># Data from 11 healthy controls for serum parameters, data from 25 healthy controls for zonulin in stool, median of healthy controls from the kit description for calprotectin</p></fn>
<fn id="t003fn002"><p>*** p&lt;0.001 compared to MetS</p></fn>
<fn id="t003fn003"><p>* p = 0.017 compared to MetS.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Bile acids</title>
<p>Total bile acids in serum were within the normal range in 26 out of 28 patients. In two patients, total bile acids were slightly elevated (8.2 and 6.9μmol/l; upper limit of normal: 6.5μmol/). No difference in individual bile acids or total bile acids was found between patients with MetS and healthy controls. Proportions of primary (cholic acid, CA; chenodeoxycholic acid, CDCA) and secondary (deoxycholic acid, DCA; litocholic acid, LCA; ursodeoxycholic acid, UDCA) as well as proportions of taurine- or glycine conjugated bile acids were unaltered in MetS when compared to healthy controls. Absolute and relative amounts of individual bile acids, primary, secondary or proportions of taurine- or glycine conjugated bile acids did not change after consumption of <italic>Lc</italic>S for 12 weeks. No compelling evidence for a correlation between serum bile acids and markers of gut barrier disruption and inflammation was found.</p>
</sec>
</sec>
<sec id="sec016" sec-type="conclusions">
<title>Discussion</title>
<p>We found that the <italic>Bacteroidetes/Firmicutes</italic> ratio, markers of gut barrier disruption and inflammation of patients with MetS differ significantly from healthy controls. Supplementation with <italic>Lc</italic>S increased the abundance of <italic>Parabacteroides</italic> but did not influence any other markers investigated in this study. Serum bile acid profile in MetS was not different to healthy controls.</p>
<p>We could confirm previously published findings of increased <italic>Firmicutes</italic> and decreased <italic>Bacteroidetes</italic> in obesity and MetS. [<xref rid="pone.0141399.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0141399.ref038" ref-type="bibr">38</xref>] The gut microbiota has been shown to influence energy extraction from diet, regulation of lipogenesis and innate immunity and therefore plays an important role in the pathogenesis of MetS. [<xref rid="pone.0141399.ref039" ref-type="bibr">39</xref>] We could find the presence of two genera (<italic>Bacteroides</italic> and <italic>Prevotella</italic>) remaining stable over the study period and not influenced by <italic>Lc</italic>S. This confirms previous findings, showing no changes of the two genera, that other authors defined as enterotypes, during a 6-months controlled diet intervention. [<xref rid="pone.0141399.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0141399.ref040" ref-type="bibr">40</xref>]</p>
<p>An interesting species–<italic>Akkermansia muciniphila</italic>–has been associated with weight gain, insulin resistance and inflammatory changes. [<xref rid="pone.0141399.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0141399.ref042" ref-type="bibr">42</xref>] In our study we were not able to reproduce this finding.</p>
<p>The supplementation with <italic>Lc</italic>S led to a significant increase in <italic>Parabacteroides</italic> (phylum <italic>Bacteroidetes)</italic>. From our data we cannot explain this finding, we can only hypothesize that <italic>Lc</italic>S might lead to ecological rearrangements in gut microbiota leading to this increase in <italic>Parabacteroides</italic>. <italic>Parabacteroides</italic> derive energy mainly from fermentation from carbohydrates or proteins, however the amount of carbohydrates in the milk drink is probably too small to be responsible for this increase. It is unclear, if an increase of <italic>Parabacteroides</italic> is beneficial. A shift from <italic>Firmicutes</italic> towards <italic>Bacteroidetes</italic> could be seen as beneficial in metabolic disorders [<xref rid="pone.0141399.ref043" ref-type="bibr">43</xref>] and dietary supplementation of resistant starch has been shown to increase <italic>Parabacteroides</italic> [<xref rid="pone.0141399.ref044" ref-type="bibr">44</xref>], whereas a reduction was associated with recurrence in Crohn´s disease. [<xref rid="pone.0141399.ref045" ref-type="bibr">45</xref>] Contrary, in non-alcoholic steatohepatitis, a higher abundance of <italic>Parabacteroides</italic> was observed. [<xref rid="pone.0141399.ref046" ref-type="bibr">46</xref>] Since we previously published that supplementation with <italic>Lc</italic>S did not influence clinical and biochemical parameters of glucose metabolism, inflammation and innate immune response [<xref rid="pone.0141399.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0141399.ref021" ref-type="bibr">21</xref>], the relevance of our observation is unclear and cannot be answered by our study design. For more detailed information concerning abundance of gut microbiota see <xref rid="pone.0141399.s004" ref-type="supplementary-material">S2 Table</xref>.</p>
<p>We have chosen to study <italic>Lactobacillus casei</italic> Shirota for several reasons. This commercially available milk drink delivers a relatively high bacterial number in a relatively small volume. <italic>Lc</italic>S has been proven to survive the passage through the stomach and is still present in the lower intestinal tract [<xref rid="pone.0141399.ref047" ref-type="bibr">47</xref>–<xref rid="pone.0141399.ref049" ref-type="bibr">49</xref>]. Within previous studies <italic>Lc</italic>S appeared to be effective in modulating natural killer cell [<xref rid="pone.0141399.ref050" ref-type="bibr">50</xref>] and neutrophil function [<xref rid="pone.0141399.ref051" ref-type="bibr">51</xref>]. Previous studies detected <italic>Lc</italic>S in stool (both by PCR and culture) already after 7 days of ingestion of an <italic>Lc</italic>S containing milk drink [<xref rid="pone.0141399.ref052" ref-type="bibr">52</xref>–<xref rid="pone.0141399.ref054" ref-type="bibr">54</xref>]. In those studies, different milk drinks with 5–15 times higher daily concentrations of <italic>Lc</italic>S compared to our study were used. <italic>Lc</italic>S was also detected in stool of European subjects, taking the same product we used in our study, using culture techniques for <italic>Lc</italic>S detection. [<xref rid="pone.0141399.ref055" ref-type="bibr">55</xref>, <xref rid="pone.0141399.ref056" ref-type="bibr">56</xref>] With the methodology we used we could not detect an increase in <italic>Lactobacillus</italic> genera by probiotic supplementation in stool samples. This is not unexpected considering the number of reads, the concentration of the product (6.5 x 10<sup>9</sup> per day) and the dilution of the probiotic milk drink in the gut with a bacterial count of about 10<sup>14</sup> cells. Therefore methodological limitations (limited number of reads per sample), differences in patient population and/or in the product can explain the different findings between our study and previous data.</p>
<p>In animal models increased gut permeability is associated with increased translocation of bacterial products and contributes to insulin resistance. [<xref rid="pone.0141399.ref017" ref-type="bibr">17</xref>] In a previous study we could show that subjects with MetS have increased gastroduodenal and small intestinal permeability compared to healthy controls. [<xref rid="pone.0141399.ref020" ref-type="bibr">20</xref>] Zonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions [<xref rid="pone.0141399.ref057" ref-type="bibr">57</xref>–<xref rid="pone.0141399.ref059" ref-type="bibr">59</xref>] and a positive correlation between zonulin, obesity and insulin resistance has been found recently. [<xref rid="pone.0141399.ref060" ref-type="bibr">60</xref>] Calprotectin, a protein expressed in neutrophil granulocytes, is a marker of intestinal inflammation. In accordance with our previous finding of increased gut permeability in MetS [<xref rid="pone.0141399.ref020" ref-type="bibr">20</xref>], zonulin and calprotectin levels were significantly elevated in stool but similar in serum of MetS patients compared to healthy controls. In contrast to animal and human studies that showed decreased faecal calprotectin levels by administration of a probiotic [<xref rid="pone.0141399.ref061" ref-type="bibr">61</xref>, <xref rid="pone.0141399.ref062" ref-type="bibr">62</xref>], we could not find any influence of <italic>Lc</italic>S supplementation on zonulin or calprotectin levels.</p>
<p>Bile acids have been proposed as potential modulators of gut permeability. In a mouse model high fat diet has been shown to decrease UDCA but increase DCA. In this model DCA increased gut permeability by a direct, non-inflammatory mechanism. [<xref rid="pone.0141399.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0141399.ref014" ref-type="bibr">14</xref>] <italic>Ex vivo</italic> data suggest that selected bile acids modulate intestinal permeability via rearrangement at the tight junction level.[<xref rid="pone.0141399.ref063" ref-type="bibr">63</xref>] In contrast to high fat diet models, genetically obese mice did not show increased gut permeability or bile acid pool hydrophobicity. [<xref rid="pone.0141399.ref064" ref-type="bibr">64</xref>] Furthermore, bile acids may directly impact on glucose metabolism. Dietary increase of bile acid pool size in a rat model resulted in a reduction of fat mass through an increase in energy expenditure. [<xref rid="pone.0141399.ref065" ref-type="bibr">65</xref>] A reduction of bile acid pool size increased body weight gain and worsened glucose intolerance induced by the high fat diet and led to a pronounced worsening of the changes in liver and adipose tissue. [<xref rid="pone.0141399.ref066" ref-type="bibr">66</xref>]</p>
<p>Human data are scarce. A biosynthetic bile acid precursor is increased in patients with MetS and T2DM, but this study did not investigate gut permeability. [<xref rid="pone.0141399.ref067" ref-type="bibr">67</xref>]. We could not find differences in the serum bile acid profiles between MetS patients and healthy controls. Bile acid composition was not influenced by <italic>Lc</italic>S treatment. Unfortunately we were not able to analyze bile acids in stool due to lack of material.</p>
<p>Our study has some limitations: Due to the small sample size individual differences might have outweighed the effects of <italic>Lc</italic>S administration. Furthermore our healthy controls were significantly younger than our patient cohort. Age impacts on gut microbiota composition, but during adulthood the microbiota composition is relatively stable. [<xref rid="pone.0141399.ref068" ref-type="bibr">68</xref>] The <italic>Bacteroidetes/Firmicutes</italic> ratio decreases after infancy and rises again over the age of 70, but is reported to be stable in the age range of our controls and patients. [<xref rid="pone.0141399.ref069" ref-type="bibr">69</xref>]</p>
<p>This study suggests that investigating gut microbiota composition is challenging and interventions are difficult. Further studies are necessary to unravel the underlying mechanisms and find targeted therapeutic approaches for the complex interplay of gut microbiota and host metabolism.</p>
</sec>
<sec id="sec017">
<title>Supporting Information</title>
<supplementary-material id="pone.0141399.s001" xlink:href="info:doi/10.1371/journal.pone.0141399.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:type="simple">
<label>S1 CONSORT Checklist</label>
<caption>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0141399.s002" xlink:href="info:doi/10.1371/journal.pone.0141399.s002" mimetype="application/pdf" position="float" xlink:type="simple">
<label>S1 Study Protocol</label>
<caption>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0141399.s003" xlink:href="info:doi/10.1371/journal.pone.0141399.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Barcoded primer sequences used in this study.</title>
<p>Amplicons were sequenced from the Titanium A adaptor (CCATCTCATCCCTGCGTGTCTCCGAC), followed by a 4 bases key sequence (TCAG) and the 10 bases barcode. The reverse primer was used with the Titanium B adaptor (CCTATCCCCTGTGTGCCTTGGCAGTC), the key sequence and the target specific sequence but without barcode sequence (CCTATCCCCTGTGTGCCTTGGCAGTC TCAG ATTACCGCGGCTGCTGG).</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0141399.s004" xlink:href="info:doi/10.1371/journal.pone.0141399.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>Abundance of gut microbiota concerning <italic>Lc</italic>S supplementation.</title>
<p>Median abundance is given for each group.</p>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We gratefully acknowledge the technical help of Michaela Eder, Barbara Leopold, Daniela Blattl, Anja Sinnitsch, Maria Schäffer and all volunteers who participated in the study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0141399.ref001"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">WHO. Obesity and overweight. Fact sheet. 2014;131.</mixed-citation></ref>
<ref id="pone.0141399.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomas</surname> <given-names>GN</given-names></name>, <name name-style="western"><surname>Schooling</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>McGhee</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Ho</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Wat</surname> <given-names>NM</given-names></name>, <etal>et al</etal>. <article-title>Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study</article-title>. <source>Clinical endocrinology</source>. <year>2007</year>;<volume>66</volume>(<issue>5</issue>):<fpage>666</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2265.2007.02798.x" xlink:type="simple">10.1111/j.1365-2265.2007.02798.x</ext-link></comment> <object-id pub-id-type="pmid">17381490</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">Prospective Studies Collaboration</collab>, <name name-style="western"><surname>Whitlock</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lewington</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sherliker</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Clarke</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Emberson</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies</article-title>. <source>Lancet</source>. <year>2009</year>;<volume>373</volume>(<issue>9669</issue>):<fpage>1083</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)60318-4" xlink:type="simple">10.1016/S0140-6736(09)60318-4</ext-link></comment> <object-id pub-id-type="pmid">19299006</object-id>; PubMed Central PMCID: PMC2662372.</mixed-citation></ref>
<ref id="pone.0141399.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Esteve</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Ricart</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Fernandez-Real</surname> <given-names>JM</given-names></name>. <article-title>Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?</article-title> <source>Current opinion in clinical nutrition and metabolic care</source>. <year>2011</year>;<volume>14</volume>(<issue>5</issue>):<fpage>483</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MCO.0b013e328348c06d" xlink:type="simple">10.1097/MCO.0b013e328348c06d</ext-link></comment> <object-id pub-id-type="pmid">21681087</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Backhed</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Turnbaugh</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lozupone</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JI</given-names></name>. <article-title>Obesity alters gut microbial ecology</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>31</issue>):<fpage>11070</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">16033867</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Backhed</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ley</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Sonnenburg</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Peterson</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JI</given-names></name>. <article-title>Host-bacterial mutualism in the human intestine</article-title>. <source>Science</source>. <year>2005</year>;<volume>307</volume>(<issue>5717</issue>):<fpage>1915</fpage>–<lpage>20</lpage>. <object-id pub-id-type="pmid">15790844</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duncan</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Lobley</surname> <given-names>GE</given-names></name>, <name name-style="western"><surname>Holtrop</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ince</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Johnstone</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Louis</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Human colonic microbiota associated with diet, obesity and weight loss</article-title>. <source>Int J Obes (Lond)</source>. <year>2008</year>;<volume>32</volume>(<issue>11</issue>):<fpage>1720</fpage>–<lpage>4</lpage>. Epub 2008/09/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ijo.2008.155" xlink:type="simple">10.1038/ijo.2008.155</ext-link></comment> ijo2008155 [pii]. <object-id pub-id-type="pmid">18779823</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schwiertz</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Taras</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Schafer</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Beijer</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bos</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Donus</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Microbiota and SCFA in lean and overweight healthy subjects</article-title>. <source>Obesity (Silver Spring)</source>. <year>2010</year>;<volume>18</volume>(<issue>1</issue>):<fpage>190</fpage>–<lpage>5</lpage>. Epub 2009/06/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/oby.2009.167" xlink:type="simple">10.1038/oby.2009.167</ext-link></comment> oby2009167 [pii]. <object-id pub-id-type="pmid">19498350</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zupancic</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Cantarel</surname> <given-names>BL</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Drabek</surname> <given-names>EF</given-names></name>, <name name-style="western"><surname>Ryan</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Cirimotich</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>8</issue>):<fpage>e43052</fpage>. Epub 2012/08/21. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0043052" xlink:type="simple">10.1371/journal.pone.0043052</ext-link></comment> PONE-D-11-23689 [pii]. <object-id pub-id-type="pmid">22905200</object-id>; PubMed Central PMCID: PMC3419686.</mixed-citation></ref>
<ref id="pone.0141399.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>DiBaise</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Zuccolo</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kudrna</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Braidotti</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Human gut microbiota in obesity and after gastric bypass</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>(<issue>7</issue>):<fpage>2365</fpage>–<lpage>70</lpage>. Epub 2009/01/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0812600106" xlink:type="simple">10.1073/pnas.0812600106</ext-link></comment> 0812600106 [pii]. <object-id pub-id-type="pmid">19164560</object-id>; PubMed Central PMCID: PMC2629490.</mixed-citation></ref>
<ref id="pone.0141399.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Creely</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>McTernan</surname> <given-names>PG</given-names></name>, <name name-style="western"><surname>Kusminski</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Da Silva</surname> <given-names>NF</given-names></name>, <name name-style="western"><surname>Khanolkar</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes</article-title>. <source>American journal of physiologyEndocrinology and metabolism</source>. <year>2007</year>;<volume>292</volume>(<issue>3</issue>):<fpage>E740</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpendo.00302.2006" xlink:type="simple">10.1152/ajpendo.00302.2006</ext-link></comment></mixed-citation></ref>
<ref id="pone.0141399.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Vogensen</surname> <given-names>FK</given-names></name>, <name name-style="western"><surname>van den Berg</surname> <given-names>FW</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Andreasen</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>BK</given-names></name>, <etal>et al</etal>. <article-title>Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e9085</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0009085" xlink:type="simple">10.1371/journal.pone.0009085</ext-link></comment> <object-id pub-id-type="pmid">20140211</object-id>; PubMed Central PMCID: PMC2816710.</mixed-citation></ref>
<ref id="pone.0141399.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stenman</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Holma</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Eggert</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Korpela</surname> <given-names>R</given-names></name>. <article-title>A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2013</year>;<volume>304</volume>(<issue>3</issue>):<fpage>G227</fpage>–<lpage>34</lpage>. Epub 2012/12/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpgi.00267.2012" xlink:type="simple">10.1152/ajpgi.00267.2012</ext-link></comment> ajpgi.00267.2012 [pii]. <object-id pub-id-type="pmid">23203158</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stenman</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Holma</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Korpela</surname> <given-names>R</given-names></name>. <article-title>High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids</article-title>. <source>World J Gastroenterol</source>. <year>2012</year>;<volume>18</volume>(<issue>9</issue>):<fpage>923</fpage>–<lpage>9</lpage>. Epub 2012/03/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3748/wjg.v18.i9.923" xlink:type="simple">10.3748/wjg.v18.i9.923</ext-link></comment> <object-id pub-id-type="pmid">22408351</object-id>; PubMed Central PMCID: PMC3297051.</mixed-citation></ref>
<ref id="pone.0141399.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cani</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Delzenne</surname> <given-names>NM</given-names></name>. <article-title>The role of the gut microbiota in energy metabolism and metabolic disease</article-title>. <source>Current pharmaceutical design</source>. <year>2009</year>;<volume>15</volume>(<issue>13</issue>):<fpage>1546</fpage>–<lpage>58</lpage>. <object-id pub-id-type="pmid">19442172</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cani</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Delzenne</surname> <given-names>NM</given-names></name>. <article-title>Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota</article-title>. <source>Current opinion in pharmacology</source>. <year>2009</year>;<volume>9</volume>(<issue>6</issue>):<fpage>737</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.coph.2009.06.016" xlink:type="simple">10.1016/j.coph.2009.06.016</ext-link></comment> <object-id pub-id-type="pmid">19628432</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cani</surname> <given-names>PD</given-names></name>, <name name-style="western"><surname>Bibiloni</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Knauf</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Waget</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Neyrinck</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Delzenne</surname> <given-names>NM</given-names></name>, <etal>et al</etal>. <article-title>Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice</article-title>. <source>Diabetes</source>. <year>2008</year>;<volume>57</volume>(<issue>6</issue>):<fpage>1470</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/db07-1403" xlink:type="simple">10.2337/db07-1403</ext-link></comment> <object-id pub-id-type="pmid">18305141</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naito</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yoshida</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Makino</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kounoshi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kunihiro</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice</article-title>. <source>J Appl Microbiol</source>. <year>2011</year>;<volume>110</volume>(<issue>3</issue>):<fpage>650</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2672.2010.04922.x" xlink:type="simple">10.1111/j.1365-2672.2010.04922.x</ext-link></comment> <object-id pub-id-type="pmid">21281408</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andreasen</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Pedersen-Skovsgaard</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Berg</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Moller</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Svendsen</surname> <given-names>KD</given-names></name>, <etal>et al</etal>. <article-title>Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects</article-title>. <source>Br J Nutr</source>. <year>2010</year>;<volume>104</volume>(<issue>12</issue>):<fpage>1831</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S0007114510002874" xlink:type="simple">10.1017/S0007114510002874</ext-link></comment> <object-id pub-id-type="pmid">20815975</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leber</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tripolt</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Blattl</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Eder</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wascher</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Pieber</surname> <given-names>TR</given-names></name>, <etal>et al</etal>. <article-title>The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study</article-title>. <source>Eur J Clin Nutr</source>. <year>2012</year>;<volume>66</volume>(<issue>10</issue>):<fpage>1110</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ejcn.2012.103" xlink:type="simple">10.1038/ejcn.2012.103</ext-link></comment> <object-id pub-id-type="pmid">22872030</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tripolt</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Leber</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Blattl</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Eder</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wonisch</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Scharnagl</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome-A pilot study</article-title>. <source>J Dairy Sci</source>. <year>2012</year>. Epub 2012/11/21. S0022-0302(12)00847-8 [pii] <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3168/jds.2012-5863" xlink:type="simple">10.3168/jds.2012-5863</ext-link></comment> <object-id pub-id-type="pmid">23164226</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alberti</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Eckel</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Grundy</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Zimmet</surname> <given-names>PZ</given-names></name>, <name name-style="western"><surname>Cleeman</surname> <given-names>JI</given-names></name>, <name name-style="western"><surname>Donato</surname> <given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity</article-title>. <source>Circulation</source>. <year>2009</year>;<volume>120</volume>(<issue>16</issue>):<fpage>1640</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/circulationaha.109.192644" xlink:type="simple">10.1161/circulationaha.109.192644</ext-link></comment> <object-id pub-id-type="pmid">19805654</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baker</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Cowan</surname> <given-names>DA</given-names></name>. <article-title>Review and re-analysis of domain-specific 16S primers</article-title>. <source>J Microbiol Methods</source>. <year>2003</year>;<volume>55</volume>(<issue>3</issue>):<fpage>541</fpage>–<lpage>55</lpage>. <object-id pub-id-type="pmid">14607398</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kodama</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Harayama</surname> <given-names>S</given-names></name>. <article-title>Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting</article-title>. <source>J Microbiol Methods</source>. <year>2001</year>;<volume>44</volume>(<issue>3</issue>):<fpage>253</fpage>–<lpage>62</lpage>. <object-id pub-id-type="pmid">11240048</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kump</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Grochenig</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Lackner</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Trajanoski</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Reicht</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hoffmann</surname> <given-names>KM</given-names></name>, <etal>et al</etal>. <article-title>Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis</article-title>. <source>Inflammatory bowel diseases</source>. <year>2013</year>;<volume>19</volume>(<issue>10</issue>):<fpage>2155</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MIB.0b013e31829ea325" xlink:type="simple">10.1097/MIB.0b013e31829ea325</ext-link></comment> <object-id pub-id-type="pmid">23899544</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stojakovic</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Putz-Bankuti</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fauler</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Scharnagl</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stadlbauer</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid</article-title>. <source>Hepatology</source>. <year>2007</year>;<volume>46</volume>(<issue>3</issue>):<fpage>776</fpage>–<lpage>84</lpage>. Epub 2007/08/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.21741" xlink:type="simple">10.1002/hep.21741</ext-link></comment> <object-id pub-id-type="pmid">17668874</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huse</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Welch</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Morrison</surname> <given-names>HG</given-names></name>, <name name-style="western"><surname>Sogin</surname> <given-names>ML</given-names></name>. <article-title>Ironing out the wrinkles in the rare biosphere through improved OTU clustering</article-title>. <source>Environ Microbiol</source>. <year>2010</year>;<volume>12</volume>(<issue>7</issue>):<fpage>1889</fpage>–<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-2920.2010.02193.x" xlink:type="simple">10.1111/j.1462-2920.2010.02193.x</ext-link></comment> <object-id pub-id-type="pmid">20236171</object-id>; PubMed Central PMCID: PMC2909393.</mixed-citation></ref>
<ref id="pone.0141399.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caporaso</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Kuczynski</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stombaugh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bittinger</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bushman</surname> <given-names>FD</given-names></name>, <name name-style="western"><surname>Costello</surname> <given-names>EK</given-names></name>, <etal>et al</etal>. <article-title>QIIME allows analysis of high-throughput community sequencing data</article-title>. <source>Nature methods</source>. <year>2010</year>;<volume>7</volume>(<issue>5</issue>):<fpage>335</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.f.303" xlink:type="simple">10.1038/nmeth.f.303</ext-link></comment> <object-id pub-id-type="pmid">20383131</object-id>; PubMed Central PMCID: PMC3156573.</mixed-citation></ref>
<ref id="pone.0141399.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Edgar</surname> <given-names>RC</given-names></name>. <article-title>Search and clustering orders of magnitude faster than BLAST</article-title>. <source>Bioinformatics</source>. <year>2010</year>;<volume>26</volume>(<issue>19</issue>):<fpage>2460</fpage>–<lpage>1</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btq461" xlink:type="simple">10.1093/bioinformatics/btq461</ext-link></comment> <object-id pub-id-type="pmid">20709691</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Garrity</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Tiedje</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Cole</surname> <given-names>JR</given-names></name>. <article-title>Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy</article-title>. <source>Appl Environ Microbiol</source>. <year>2007</year>;<volume>73</volume>(<issue>16</issue>):<fpage>5261</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AEM.00062-07" xlink:type="simple">10.1128/AEM.00062-07</ext-link></comment> <object-id pub-id-type="pmid">17586664</object-id>; PubMed Central PMCID: PMC1950982.</mixed-citation></ref>
<ref id="pone.0141399.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McDonald</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Goodrich</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nawrocki</surname> <given-names>EP</given-names></name>, <name name-style="western"><surname>DeSantis</surname> <given-names>TZ</given-names></name>, <name name-style="western"><surname>Probst</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea</article-title>. <source>ISME J</source>. <year>2012</year>;<volume>6</volume>(<issue>3</issue>):<fpage>610</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ismej.2011.139" xlink:type="simple">10.1038/ismej.2011.139</ext-link></comment> <object-id pub-id-type="pmid">22134646</object-id>; PubMed Central PMCID: PMC3280142.</mixed-citation></ref>
<ref id="pone.0141399.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Caporaso</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Bittinger</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bushman</surname> <given-names>FD</given-names></name>, <name name-style="western"><surname>DeSantis</surname> <given-names>TZ</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>R</given-names></name>. <article-title>PyNAST: a flexible tool for aligning sequences to a template alignment</article-title>. <source>Bioinformatics</source>. <year>2010</year>;<volume>26</volume>(<issue>2</issue>):<fpage>266</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/bioinformatics/btp636" xlink:type="simple">10.1093/bioinformatics/btp636</ext-link></comment> <object-id pub-id-type="pmid">19914921</object-id>; PubMed Central PMCID: PMC2804299.</mixed-citation></ref>
<ref id="pone.0141399.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haas</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Gevers</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Earl</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Feldgarden</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ward</surname> <given-names>DV</given-names></name>, <name name-style="western"><surname>Giannoukos</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons</article-title>. <source>Genome research</source>. <year>2011</year>;<volume>21</volume>(<issue>3</issue>):<fpage>494</fpage>–<lpage>504</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.112730.110" xlink:type="simple">10.1101/gr.112730.110</ext-link></comment> <object-id pub-id-type="pmid">21212162</object-id>; PubMed Central PMCID: PMC3044863.</mixed-citation></ref>
<ref id="pone.0141399.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Dehal</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Arkin</surname> <given-names>AP</given-names></name>. <article-title>FastTree 2—approximately maximum-likelihood trees for large alignments</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>3</issue>):<fpage>e9490</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0009490" xlink:type="simple">10.1371/journal.pone.0009490</ext-link></comment> <object-id pub-id-type="pmid">20224823</object-id>; PubMed Central PMCID: PMC2835736.</mixed-citation></ref>
<ref id="pone.0141399.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Backhed</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Manchester</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Semenkovich</surname> <given-names>CF</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JI</given-names></name>. <article-title>Mechanisms underlying the resistance to diet-induced obesity in germ-free mice</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>;<volume>104</volume>(<issue>3</issue>):<fpage>979</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0605374104" xlink:type="simple">10.1073/pnas.0605374104</ext-link></comment> <object-id pub-id-type="pmid">17210919</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley</surname> <given-names>RE</given-names></name>. <article-title>Obesity and the human microbiome</article-title>. <source>Current opinion in gastroenterology</source>. <year>2010</year>;<volume>26</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/MOG.0b013e328333d751" xlink:type="simple">10.1097/MOG.0b013e328333d751</ext-link></comment> <object-id pub-id-type="pmid">19901833</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tilg</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kaser</surname> <given-names>A</given-names></name>. <article-title>Gut microbiome, obesity, and metabolic dysfunction</article-title>. <source>The Journal of clinical investigation</source>. <year>2011</year>;<volume>121</volume>(<issue>6</issue>):<fpage>2126</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/jci58109; 10.1172/jci58109" xlink:type="simple">10.1172/jci58109; 10.1172/jci58109</ext-link></comment> <object-id pub-id-type="pmid">21633181</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tremaroli</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Backhed</surname> <given-names>F</given-names></name>. <article-title>Functional interactions between the gut microbiota and host metabolism</article-title>. <source>Nature</source>. <year>2012</year>;<volume>489</volume>(<issue>7415</issue>):<fpage>242</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature11552" xlink:type="simple">10.1038/nature11552</ext-link></comment> <object-id pub-id-type="pmid">22972297</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Parekh</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Arusi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Vinik</surname> <given-names>AI</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>DA</given-names></name>. <article-title>The Role and Influence of Gut Microbiota in Pathogenesis and Management of Obesity and Metabolic Syndrome</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2014</year>;<volume>5</volume>:<fpage>47</fpage>. Epub 2014/04/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fendo.2014.00047" xlink:type="simple">10.3389/fendo.2014.00047</ext-link></comment> <object-id pub-id-type="pmid">24778627</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roager</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Licht</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Poulsen</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Bahl</surname> <given-names>MI</given-names></name>. <article-title>Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet</article-title>. <source>Appl Environ Microbiol</source>. <year>2014</year>;<volume>80</volume>(<issue>3</issue>):<fpage>1142</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AEM.03549-13" xlink:type="simple">10.1128/AEM.03549-13</ext-link></comment> <object-id pub-id-type="pmid">24296500</object-id>; PubMed Central PMCID: PMC3911217.</mixed-citation></ref>
<ref id="pone.0141399.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title>. <source>Nature</source>. <year>2012</year>;<volume>490</volume>(<issue>7418</issue>):<fpage>55</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature11450" xlink:type="simple">10.1038/nature11450</ext-link></comment> <object-id pub-id-type="pmid">23023125</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukuda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ohno</surname> <given-names>H</given-names></name>. <article-title>Gut microbiome and metabolic diseases</article-title>. <source>Seminars in immunopathology</source>. <year>2014</year>;<volume>36</volume>(<issue>1</issue>):<fpage>103</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00281-013-0399-z" xlink:type="simple">10.1007/s00281-013-0399-z</ext-link></comment> <object-id pub-id-type="pmid">24196453</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ley</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Backhed</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Turnbaugh</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lozupone</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>RD</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>JI</given-names></name>. <article-title>Obesity alters gut microbial ecology</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>31</issue>):<fpage>11070</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0504978102" xlink:type="simple">10.1073/pnas.0504978102</ext-link></comment> <object-id pub-id-type="pmid">16033867</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinez</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Duffy</surname> <given-names>PR</given-names></name>, <name name-style="western"><surname>Schlegel</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Walter</surname> <given-names>J</given-names></name>. <article-title>Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>11</issue>):<fpage>e15046</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0015046" xlink:type="simple">10.1371/journal.pone.0015046</ext-link></comment> <object-id pub-id-type="pmid">21151493</object-id>; PubMed Central PMCID: PMC2993935.</mixed-citation></ref>
<ref id="pone.0141399.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Cruz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Buckley</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sim</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Prideaux</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Specific Mucosa-Associated Microbiota in Crohn's Disease at the Time of Resection are Associated with Early Disease Recurrence: A Pilot Study</article-title>. <source>Journal of gastroenterology and hepatology</source>. <year>2014</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/jgh.12694" xlink:type="simple">10.1111/jgh.12694</ext-link></comment></mixed-citation></ref>
<ref id="pone.0141399.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname> <given-names>VW</given-names></name>, <name name-style="western"><surname>Tse</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Lam</surname> <given-names>TT</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Chim</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>WC</given-names></name>, <etal>et al</etal>. <article-title>Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis—a longitudinal study</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e62885</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0062885" xlink:type="simple">10.1371/journal.pone.0062885</ext-link></comment> <object-id pub-id-type="pmid">23638162</object-id>; PubMed Central PMCID: PMC3636208.</mixed-citation></ref>
<ref id="pone.0141399.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shirota</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Aso</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Iwabuchi</surname> <given-names>A</given-names></name>. <article-title>Studies on intestinal microflora. 1. Its constitution in healthy infants and the effect of oral administration of L. acidophilus strain Shirota</article-title>. <source>Nippon saikingaku zasshiJapanese journal of bacteriology</source>. <year>1966</year>;<volume>21</volume>(<issue>5</issue>):<fpage>274</fpage>–<lpage>83</lpage>.</mixed-citation></ref>
<ref id="pone.0141399.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spanhaak</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Havenaar</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schaafsma</surname> <given-names>G</given-names></name>. <article-title>The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans</article-title>. <source>Eur J Clin Nutr</source>. <year>1998</year>;<volume>52</volume>(<issue>12</issue>):<fpage>899</fpage>–<lpage>907</lpage>. <object-id pub-id-type="pmid">9881885</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tuohy</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Pinart-Gilberga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hoyles</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>McCartney</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>GR</given-names></name>. <article-title>Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora</article-title>. <source>J Appl Microbiol</source>. <year>2007</year>;<volume>102</volume>(<issue>4</issue>):<fpage>1026</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2672.2006.03154.x" xlink:type="simple">10.1111/j.1365-2672.2006.03154.x</ext-link></comment> <object-id pub-id-type="pmid">17381746</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takeda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Okumura</surname> <given-names>K</given-names></name>. <article-title>Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity</article-title>. <source>The Journal of nutrition</source>. <year>2007</year>;<volume>137</volume>(<issue>3</issue> Suppl 2):<fpage>791S</fpage>–<lpage>3S</lpage>. <object-id pub-id-type="pmid">17311976</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stadlbauer</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Mookerjee</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Hodges</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Davies</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Jalan</surname> <given-names>R</given-names></name>. <article-title>Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis</article-title>. <source>J Hepatol</source>. <year>2008</year>;<volume>48</volume>(<issue>6</issue>):<fpage>945</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhep.2008.02.015" xlink:type="simple">10.1016/j.jhep.2008.02.015</ext-link></comment> <object-id pub-id-type="pmid">18433921</object-id></mixed-citation></ref>
<ref id="pone.0141399.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tiengrim</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Leelaporn</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Manatsathit</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Thamlikitkul</surname> <given-names>V</given-names></name>. <article-title>Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS</article-title>. <source>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</source>. <year>2012</year>;<volume>95</volume> <issue>Suppl 2</issue>:<fpage>S42</fpage>–<lpage>7</lpage>. Epub 2012/05/12. <object-id pub-id-type="pmid">22574528</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yuki</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mike</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tagami</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ohwaki</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies</article-title>. <source>International journal of food microbiology</source>. <year>1999</year>;<volume>48</volume>(<issue>1</issue>):<fpage>51</fpage>–<lpage>7</lpage>. Epub 1999/06/22. <object-id pub-id-type="pmid">10375134</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fujimoto</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Matsuki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sasamoto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tomii</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>K</given-names></name>. <article-title>Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA</article-title>. <source>International journal of food microbiology</source>. <year>2008</year>;<volume>126</volume>(<issue>1–2</issue>):<fpage>210</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijfoodmicro.2008.05.022" xlink:type="simple">10.1016/j.ijfoodmicro.2008.05.022</ext-link></comment> <object-id pub-id-type="pmid">18573558</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Oishi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Asahara</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Takada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yuki</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>M-RTLV agar, a novel selective medium to distinguish Lactobacillus casei and Lactobacillus paracasei from Lactobacillus rhamnosus</article-title>. <source>International journal of food microbiology</source>. <year>2010</year>;<volume>139</volume>(<issue>3</issue>):<fpage>154</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijfoodmicro.2010.03.019" xlink:type="simple">10.1016/j.ijfoodmicro.2010.03.019</ext-link></comment> <object-id pub-id-type="pmid">20385416</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tilley</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Keppens</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kushiro</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Takada</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sakai</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Vaneechoutte</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A probiotic fermented milk drink containing Lactobacillus cassei strain Shirota improves stool consistency of subjects with hard stools</article-title>. <source>International Journal of Probiotics and Prebiotics</source>. <year>2014</year>;<volume>9</volume>(<issue>1–2</issue>):<fpage>23</fpage>–<lpage>30</lpage>.</mixed-citation></ref>
<ref id="pone.0141399.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fasano</surname> <given-names>A</given-names></name>. <article-title>Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin</article-title>. <source>Ann N Y Acad Sci</source>. <year>2000</year>;<volume>915</volume>:<fpage>214</fpage>–<lpage>22</lpage>. Epub 2001/02/24. <object-id pub-id-type="pmid">11193578</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Uzzau</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Goldblum</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Fasano</surname> <given-names>A</given-names></name>. <article-title>Human zonulin, a potential modulator of intestinal tight junctions</article-title>. <source>J Cell Sci</source>. <year>2000</year>;<volume>113</volume> <issue>Pt 24</issue>:<fpage>4435</fpage>–<lpage>40</lpage>. Epub 2000/11/18. <object-id pub-id-type="pmid">11082037</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fasano</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Not</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Uzzau</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Berti</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Tommasini</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease</article-title>. <source>Lancet</source>. <year>2000</year>;<volume>355</volume>(<issue>9214</issue>):<fpage>1518</fpage>–<lpage>9</lpage>. Epub 2000/05/09. S0140-6736(00)02169-3 [pii] <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(00)02169-3" xlink:type="simple">10.1016/S0140-6736(00)02169-3</ext-link></comment> <object-id pub-id-type="pmid">10801176</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreno-Navarrete</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Sabater</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ortega</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ricart</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Fernandez-Real</surname> <given-names>JM</given-names></name>. <article-title>Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e37160</fpage>. Epub 2012/05/26. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0037160" xlink:type="simple">10.1371/journal.pone.0037160</ext-link></comment> PONE-D-12-01867 [pii]. <object-id pub-id-type="pmid">22629362</object-id>; PubMed Central PMCID: PMC3356365.</mixed-citation></ref>
<ref id="pone.0141399.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goodrich</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Fundaro</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Griffin</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Grant</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hulver</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Ponder</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Chronic administration of dietary grape seed extract increases colonic expression of gut tight junction protein occludin and reduces fecal calprotectin: a secondary analysis of healthy Wistar Furth rats</article-title>. <source>Nutr Res</source>. <year>2012</year>;<volume>32</volume>(<issue>10</issue>):<fpage>787</fpage>–<lpage>94</lpage>. Epub 2012/11/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nutres.2012.09.004" xlink:type="simple">10.1016/j.nutres.2012.09.004</ext-link></comment> S0271-5317(12)00186-8 [pii]. <object-id pub-id-type="pmid">23146776</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vulevic</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Juric</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tzortzis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>GR</given-names></name>. <article-title>A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults</article-title>. <source>J Nutr</source>. <year>2013</year>;<volume>143</volume>(<issue>3</issue>):<fpage>324</fpage>–<lpage>31</lpage>. Epub 2013/01/11. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3945/jn.112.166132" xlink:type="simple">10.3945/jn.112.166132</ext-link></comment> jn.112.166132 [pii]. <object-id pub-id-type="pmid">23303873</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raimondi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Santoro</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Barone</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Pappacoda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Barretta</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Nanayakkara</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2008</year>;<volume>294</volume>(<issue>4</issue>):<fpage>G906</fpage>–<lpage>13</lpage>. Epub 2008/02/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajpgi.00043.2007" xlink:type="simple">10.1152/ajpgi.00043.2007</ext-link></comment> <object-id pub-id-type="pmid">18239063</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stenman</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Holma</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gylling</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Korpela</surname> <given-names>R</given-names></name>. <article-title>Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity</article-title>. <source>Br J Nutr</source>. <year>2013</year>;<volume>110</volume>(<issue>6</issue>):<fpage>1157</fpage>–<lpage>64</lpage>. Epub 2013/02/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S000711451300024X" xlink:type="simple">10.1017/S000711451300024X</ext-link></comment> <object-id pub-id-type="pmid">23442231</object-id>.</mixed-citation></ref>
<ref id="pone.0141399.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liaset</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hao</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Jorgensen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hallenborg</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>ZY</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome</article-title>. <source>The Journal of biological chemistry</source>. <year>2011</year>;<volume>286</volume>(<issue>32</issue>):<fpage>28382</fpage>–<lpage>95</lpage>. Epub 2011/06/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M111.234732" xlink:type="simple">10.1074/jbc.M111.234732</ext-link></comment> <object-id pub-id-type="pmid">21680746</object-id>; PubMed Central PMCID: PMC3151081.</mixed-citation></ref>
<ref id="pone.0141399.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watanabe</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Horai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Houten</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Morimoto</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sugizaki</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Arita</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure</article-title>. <source>The Journal of biological chemistry</source>. <year>2011</year>;<volume>286</volume>(<issue>30</issue>):<fpage>26913</fpage>–<lpage>20</lpage>. Epub 2011/06/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M111.248203" xlink:type="simple">10.1074/jbc.M111.248203</ext-link></comment> <object-id pub-id-type="pmid">21632533</object-id>; PubMed Central PMCID: PMC3143650.</mixed-citation></ref>
<ref id="pone.0141399.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steiner</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Othman</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Saely</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Rein</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Drexel</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>von Eckardstein</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e25006</fpage>. Epub 2011/11/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0025006" xlink:type="simple">10.1371/journal.pone.0025006</ext-link></comment> <object-id pub-id-type="pmid">22110577</object-id>; PubMed Central PMCID: PMC3215718.</mixed-citation></ref>
<ref id="pone.0141399.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voreades</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kozil</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Weir</surname> <given-names>TL</given-names></name>. <article-title>Diet and the development of the human intestinal microbiome</article-title>. <source>Frontiers in microbiology</source>. <year>2014</year>;<volume>5</volume>:<fpage>494</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fmicb.2014.00494" xlink:type="simple">10.3389/fmicb.2014.00494</ext-link></comment> <object-id pub-id-type="pmid">25295033</object-id>; PubMed Central PMCID: PMC4170138.</mixed-citation></ref>
<ref id="pone.0141399.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mariat</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Firmesse</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Levenez</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Guimaraes</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Sokol</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Dore</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age</article-title>. <source>BMC Microbiol</source>. <year>2009</year>;<volume>9</volume>:<fpage>123</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2180-9-123" xlink:type="simple">10.1186/1471-2180-9-123</ext-link></comment> <object-id pub-id-type="pmid">19508720</object-id>; PubMed Central PMCID: PMC2702274.</mixed-citation></ref>
</ref-list>
</back>
</article>